Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $593.4400 (0.37%) ($575.8900 - $597.1500) on Tue. Jun. 16, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.33% (three month average) | RSI | 70 | Latest Price | $593.4400(0.37%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -0.5% a day on average for past five trading days. | Weekly Trend | REGN advances 0.3% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(55%) XLV(45%) SPLV(39%) IVW(37%) IWF(36%) | Factors Impacting REGN price | REGN will decline at least -1.665% in a week (0% probabilities). VIXM(-21%) VXX(-7%) UUP(-7%) TBT(-5%) IYT(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.665% (StdDev 3.33%) | Hourly BBV | 0.2 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $595.43(-0.33%) | 10 Day Moving Average | $598.62(-0.87%) | 20 Day Moving Average | $588.24(0.88%) | To recent high | -4% | To recent low | 38.5% | Market Cap | $62.922b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |